(Q43074669)

13 November 2017

Removal of asymmetric dimethylarginine during artificial liver support using fractionated plasma separation and adsorption (English)

1 reference

13 November 2017

Kinan Rifai

1

1 reference

13 November 2017

Stefanie M Bode-Boeger

2

1 reference

13 November 2017

Jens Martens-Lobenhoffer

3

1 reference

13 November 2017

Thomas Ernst

4

1 reference

13 November 2017

Ulrich Kretschmer

5

1 reference

13 November 2017

Carsten Hafer

6

1 reference

13 November 2017

Danilo Fliser

7

1 reference

13 November 2017

Michael Peter Manns

8

1 reference

13 November 2017

Jan T Kielstein

9

1 reference

13 November 2017

1 September 2010

1 reference

Scandinavian Journal of Gastroenterology

13 November 2017

1 reference

13 November 2017

45

1 reference

13 November 2017

9

1 reference

13 November 2017

1110-1115

1 reference

Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond

13 November 2017

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

Asymmetric dimethylarginine (ADMA): a key regulator of nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

Asymmetric dimethylarginine: a novel marker of risk and a potential target for therapy in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

Indices of activity of the nitric oxide system in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

Relationship of asymmetric dimethylarginine to haemodialysis hypotension.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

Albumin from human serum does not contain asymmetric dimethylarginine (ADMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

Contribution of whole blood to the control of plasma asymmetrical dimethylarginine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

The Prometheus device for extracorporeal support of combined liver and renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

Fast and efficient determination of arginine, symmetric dimethylarginine, and asymmetric dimethylarginine in biological fluids by hydrophilic-interaction liquid chromatography-electrospray tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

ADMA increases arterial stiffness and decreases cerebral blood flow in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

Asymmetrical dimethylarginine in renal disease: limits of variation or variation limits? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

ADMA correlates with portal pressure in patients with compensated cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

Detoxifying capacity and kinetics of prometheus--a new extracorporeal system for the treatment of liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

Prometheus--a new extracorporeal system for the treatment of liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

Subpressor dose asymmetric dimethylarginine modulates renal function in humans through nitric oxide synthase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.485322

10.3109/00365521.2010.485322

21 January 2018

Identifiers

DOI

1 reference

13 November 2017

1 reference